Additional file 4: of The neoepitope landscape of breast cancer: implications for immunotherapy

Figure S2. Comparison of mutations called by the current protocol versus cBioportal ( http://www.cbioportal.org ). The total number of mutations called by the current protocol (in blue) is comparable to the mutations called from cBioportal (in orange) across all three classifications of breast cancer subtype (PDF 425 kb